A Preliminary Analysis of ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors

Author(s):
Tammuella Chrisentery-Singleton, Lauren E Amos, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Emmanuelle Lagrue, Christine Knoll, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris V Quon, Mark T Reding
Publication:
Blood
Date:
November 15, 2022
Topics:
Safety, Eptacog-Beta

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.